Abstract
Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
Karim Sacré, Benoit Brihaye, Olivier Lidove, Thomas Papo, Marie-Annick Pocidalo, Laurence Cuisset and Catherine Dodé
The Journal of Rheumatology February 2008, 35 (2) 357-358;
Karim Sacré
Benoit Brihaye
Olivier Lidove
Thomas Papo
Marie-Annick Pocidalo
Laurence Cuisset
In this issue
Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
Karim Sacré, Benoit Brihaye, Olivier Lidove, Thomas Papo, Marie-Annick Pocidalo, Laurence Cuisset, Catherine Dodé
The Journal of Rheumatology Feb 2008, 35 (2) 357-358;
Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
Karim Sacré, Benoit Brihaye, Olivier Lidove, Thomas Papo, Marie-Annick Pocidalo, Laurence Cuisset, Catherine Dodé
The Journal of Rheumatology Feb 2008, 35 (2) 357-358;